KPD PHARMA
0537.774.136 · rovalta.com · 23/09/2026
KPD PHARMA
Overview
What does KPD PHARMA do?
KPD PHARMA is a Private company with limited liability incorporated in 2013. Its registered office is in Evere.
1140 Evere · BruxellesSee on map
Joint committees (1)
- 313
Trend over 8 financial years
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||||||||
| Gross margin | -1,3 k € | -3682% | 35,5 € | -99.9% | 34,2 k € | -59.6% | 84,6 k € | -7.7% | 91,7 k € | -2.8% | 94,3 k € | -1.5% | 95,8 k € | +0.2% | 95,5 k € |
| EBITDA | -1,3 k € | -141% | -526,8 € | -103% | 20,9 k € | +161% | -34,1 k € | -206% | 32,2 k € | +355% | 7,1 k € | -24.5% | 9,4 k € | +28.7% | 7,3 k € |
| Operating result | -18,6 k € | -4.2% | -17,8 k € | -589% | 3,6 k € | +107% | -51,4 k € | -1191% | 4,7 k € | +124% | -19,8 k € | -11.4% | -17,8 k € | +19.6% | -22,1 k € |
| Net result | -18,6 k € | -4.2% | -17,8 k € | -618% | 3,4 k € | +106% | -56,4 k € | -844% | -6 k € | +72.6% | -21,8 k € | -7.4% | -20,3 k € | +16.9% | -24,4 k € |
| Balance sheet | |||||||||||||||
| Equity | -2,8 k € | -118% | 15,8 k € | -53.0% | 33,7 k € | +11.4% | 30,2 k € | -65.1% | 86,6 k € | -6.5% | 92,6 k € | -19.0% | 114,3 k € | -15.1% | 134,6 k € |
| Total assets | 61 k € | -23.4% | 79,6 k € | -40.5% | 133,8 k € | -30.0% | 191 k € | -22.2% | 245,6 k € | +1.8% | 241,2 k € | -19.4% | 299,4 k € | -11.7% | 339 k € |
| Cash | 43,4 k € | -2.9% | 44,7 k € | -13.3% | 51,6 k € | -47.9% | 98,9 k € | +17.9% | 83,9 k € | +364% | 18,1 k € | -23.8% | 23,7 k € | -0.9% | 24 k € |
| Debts | 63,8 k € | 0.0% | 63,8 k € | -36.3% | 100,1 k € | -37.7% | 160,8 k € | +1.1% | 159 k € | +7.6% | 147,7 k € | -20.2% | 185 k € | -9.5% | 204,4 k € |
| Other | |||||||||||||||
| Workforce | – | – | – | 1,4 ETP | 0.0% | 1,4 ETP | +16.7% | 1,2 ETP | +20.0% | 1,0 ETP | 0.0% | 1,0 ETP | |||
Indicative valuation
As an indication, this company is worth
Board of directors
Seen on filing of 31/12/2021 · 1 active · 3 ended
Active mandates
Ended mandates
Other companies at this address
| Company | CBE no. |
|---|---|
MEDIBIB● Active | 0558.929.440 |
Financials
Full financial information
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|
| Type of account | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model |
| Start of the financial year | 01/01/2021 | 01/01/2020 | 01/01/2019 | 01/01/2018 | 01/01/2017 | 01/01/2016 |
| Closing of the financial year | 31/12/2021 | 31/12/2020 | 31/12/2019 | 31/12/2018 | 31/12/2017 | 31/12/2016 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 29/06/2022 | 11/08/2021 | 30/06/2020 | 16/07/2019 | 06/09/2018 | 19/05/2017 |
| General meeting | 02/05/2022 | 03/05/2021 | 04/05/2020 | 06/05/2019 | 07/05/2018 | 02/05/2017 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Looking for more information about this company?
Try for 7 daysAnnual accounts filings
9 filings with the NBB
| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Abridged model | 31/12/2021 | 02/05/2022 | 29/06/2022 | Dutch | |
| Abridged model | 31/12/2020 | 03/05/2021 | 11/08/2021 | Dutch | |
| Abridged model | 31/12/2019 | 04/05/2020 | 30/06/2020 | Dutch | |
| Abridged model | 31/12/2018 | 06/05/2019 | 16/07/2019 | Dutch | |
| Abridged model | 31/12/2017 | 07/05/2018 | 06/09/2018 | Dutch | |
| Abridged model | 31/12/2016 | 02/05/2017 | 19/05/2017 | Dutch | |
| Abridged model | 31/12/2015 | 02/05/2016 | 31/05/2016 | Dutch | |
| Abridged model | 31/12/2014 | 04/05/2015 | 09/06/2015 | Dutch | |
| Abridged model | 31/12/2013 | 05/05/2014 | 11/06/2014 | Dutch |
Valuation
Indicative valuation
As an indication, this company is worth
between 0 € and 100 k€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Seen on filing of 31/12/2021 · 1 active · 3 ended
Active mandates
Ended mandates
Ownership and network
Looking for more information about this company?
Try for 7 daysPublications
Belgian Official Gazette publications
Source: Belgian Official Gazette
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2021Annual accounts 2021-18,6 k €↓
- 2020Annual accounts 2020-17,8 k €↓
- 2019Annual accounts 20193,4 k €↑
- 2018Annual accounts 2018-56,4 k €↓
- 2017Annual accounts 2017-6 k €↑
- 2016Annual accounts 2016-21,8 k €↓
- 2015Annual accounts 2015-20,3 k €↑
- 2014Annual accounts 2014-24,4 k €
- 22/08/2013IncorporationPrivate company with limited liability